Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape

European Journal of Cancer

Volumn 42, Issue 8, 2006, Pages 1181-1187

  Simonetti, Oriana ^a   Goteri, Gaia ^a   Lucarini, Guendalina ^a   Filosa, Alessandra ^a   Pieramici, Tiziana ^a   Rubini, Corrado ^a   Biagini, Graziella ^a   Offidani, Annamaria ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

CCL27; CCR10; Host immune response; Immunohistochemistry; Melanoma

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CHEMOKINE CCL27; CHEMOKINE RECEPTOR CCR10; LIGAND; UNCLASSIFIED DRUG;

ARTICLE; BENIGN TUMOR; CANCER CELL; CANCER GROWTH; CANCER INVASION; CD8+ T LYMPHOCYTE; CELL DENSITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; HOST RESISTANCE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHOCYTE COUNT; MALE; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SENTINEL LYMPH NODE; SKIN CANCER; T LYMPHOCYTE; THICKNESS; TUMOR IMMUNITY;

CHEMOKINES, CC; FEMALE; HUMANS; MALE; MELANOMA; RECEPTORS, CHEMOKINE; SKIN NEOPLASMS; TUMOR ESCAPE;

EID: 33646395923     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.01.043     Document Type: Article

References (30)

1. In: Nordlund J.J., Boissy R.E., Hearing V.J., et al. (Eds). The pigmentary system: physiology and pathophysiology (1988), Oxford University Press, New York (NY)
2. In: Lejeune F.J., Chaudhuri P.K., and Das Gupta P.K. (Eds). Malignant melanoma and surgical management (1994), McGrow-Hill, New York (NY)
3. Clark W., Elder D.E., Guerry D., et al. A study of tumour progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 15 (1984) 1147-1165
4. Herlin M., Clark W.H., Rodeck U., et al. Biology of disease: biology of tumour progression in human melanocytes. Lab Invest 56 (1987) 461-474
5. Payne A.S., and Cornelius L.A. The role of chemokines in melanoma tumour growth and metastasis. J Invest Dermatol 118 (2002) 915-922
6. Muller A., Homey B., Soto H., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001) 50-56
7. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 121-127
8. Nagasawa T., Hirota S., Tachibana K., et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382 (1996) 635-681
9. Strieter R.M., DiGiovine B., Polverini S., et al. C-X-C chemokines and lung cancer angiogenesis. In: Rollins B.J. (Ed). Chemokines and cancer (1999), Humana, Clifton (NJ) 143
10. Graham G.J. Growth inhibitors in haemopoiesis and leukemogenesis. Ballieres Clin Haematol 10 (1997) 539-559
11. Strieter R.M., Polverini S., Kunkel S.L., et al. The functional role of ELR motif in C-X-C chemokine mediated angiogenesis. J Biol Chem 270 (1995) 1083-1086
12. Murakami T., Cardones A.R., Finkelstein S.E., et al. Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J Exp Med 198 (2003) 1337-1347
13. Homey B., Wang W., Soto H., et al. Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin associated chemokine CCL27 (CTAK/ALP/ILC). J Immunol 164 (2000) 3465-3470
14. Homey B., Alenius H., Muller A., et al. CCL27-CCR10 interactions regulate T cell mediated skin inflammation. Nat Med 8 (2002) 157-165
15. Morales J., Homey B., Vicari A.P., et al. CTHCK, a skin associated chemokine that preferentially attracts skin homing-memory T cells. Proc Natl Acad Sci USA 96 (1999) 14470-14475
16. Guo J., Wang B., Zhang M., et al. Macrophage-derived chemokine gene transfer results in tumour regression in murine lung carcinoma model through efficient induction of antitumour immunity. Gene Ther 9 (2002) 793-803
17. Okada N., Gao J.-.Q., Sasaki A., et al. Anti-tumour activity of chemokine is affected by both kinds of tumours and the activation state of the host's immune system: implications for chemokine-based cancer immunotherapy. Biochem Biophys Res Commun 317 (2004) 68-76
18. Lever W.F., and Schaumburg-Lever G. Histopathology of the skin. 7th ed. (1990), J.B. Lippincott, Philadelphia (PA) 756-805
19. Boon T., Coulie P.G., and Van den Eynde B. Tumour antigens recognized by T cells. Immunol Today 18 (1997) 267-268
20. Nathanson L. Spontaneous regression of malignant melanoma: a review of the literature on incidence, clinical features, and possible mechanisms. Natl Cancer Inst Monogr 44 (1976) 67-76
21. Romero P., Dunbar P.R., Valmori D., et al. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high number of antigen experienced tumour-specific cytolytic T lymphocytes. J Exp Med 188 (1998) 1641-1650
22. Clemente C.G., Mihm M.C., Bufalino R., et al. Prognostic value of tumour infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 77 (1996) 1303-1310
23. Clark Jr. W.H., Elder D.E., Guerry IV D.P., et al. Model predicting survival in stage I melanoma, based on tumour progression. J Natl Cancer Inst 81 (1989) 1893-1904
24. high regulatory T cells are overpresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 173 (2004) 1444-1453
25. Bernsen M.R., Dipestra J.H.S., van Mil P., et al. Presence and localization of T-cell subsets in relation to melanocyte differentiation antigen expression and tumour regression as assessed by immunohistochemistry and molecular analysis of microdissected T cells. J Pathol 202 (2004) 70-79
26. Lyle S., Salhany K.E., and Elder D.E. TIA-1 positive tumour-infiltrating lymphocytes in nevi and melanomas. Mod Pathol 13 (2000) 52-55
27. Lazár-Molnár E., Hegyesi H., Tóth S., et al. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 12 (2000) 547-554
28. Slominski A., Wortsman J., Carlson A.J., et al. Malignant melanoma. Arch Pathol Lab Med 125 10 (2001) 1295-1306
29. McCarthy W.H., Shaw H.M., Thompson J.F., et al. Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up study. Surg Gynecol Obstet 166 (1988) 497-502
30. Gortz A., Nibbs R.J.B., McLean P., et al. The chemokine ESkine/CCL27 displays novel modes of intracrine and paracrine function. J Immunol 169 (2002) 1387-1394